Welcome to our dedicated page for Enhabit news (Ticker: EHAB), a resource for investors and traders seeking the latest updates and insights on Enhabit stock.
Enhabit, Inc. (NYSE: EHAB), operating as Enhabit Home Health & Hospice, is a national home health and hospice provider whose activities generate a steady flow of company news and disclosures. As a public company listed on the New York Stock Exchange, Enhabit regularly issues press releases and files Form 8-K reports covering its financial results, strategic updates, leadership developments, and participation in investor conferences.
News about Enhabit often centers on quarterly earnings announcements, where the company reports net service revenue, segment performance for Home Health and Hospice, Adjusted EBITDA, and other financial and operational metrics. These releases highlight trends in home health and hospice admissions, average daily census, patient days, and segment-level profitability, as well as updates on branch openings, de novo locations, and changes in cost per patient day.
Investors following EHAB news will also see regular updates on guidance for net service revenue, Adjusted EBITDA, and Adjusted EPS, along with explanations of non-GAAP financial measures and same-store comparisons. Enhabit’s communications discuss how unusual or nonrecurring items affect its results and how management evaluates core operating performance.
Another key category of Enhabit news involves corporate and governance developments. The company has announced a CEO transition plan, retention awards for senior officers, approval of its 2025 Equity and Incentive Compensation Plan, and voting results from its annual meeting. In addition, Enhabit frequently reports on its participation in healthcare and home care conferences hosted by major financial institutions, where its leadership teams take part in fireside chats and presentations.
For readers tracking EHAB, this news flow provides insight into Enhabit’s home health and hospice operations, financial performance, capital structure, and governance decisions. Monitoring these updates can help contextualize the company’s strategic focus on patient care in the home and its reported progress across its nationwide footprint.
Enhabit, Inc. (NYSE: EHAB) has acquired Southwest Florida Home Care, Inc.’s home health agency in Fort Myers, Florida. This acquisition enhances Enhabit’s presence in Florida, increasing its total home health locations to 22. The company aims to better serve patients needing high-quality home health services in southwest Florida. Enhabit is recognized as the fourth largest provider of Medicare-certified home health services and the twelfth in hospice services nationally.
Enhabit, Inc. (NYSE: EHAB) has announced the acquisition of Southwest Florida Home Care in Fort Myers, expanding its home health service locations in Florida to 22. This strategic move enhances Enhabit's capacity to provide high-quality home health services to the southwest Florida community. Enhabit is now the fourth largest provider of Medicare-certified home health services nationwide, emphasizing its commitment to patient care expansion.
Enhabit, Inc. (NYSE: EHAB), a prominent home health and hospice provider, announced its participation in the BofA Securities Home Care Conference on December 5, 2022. During the conference, CEO Barbara Jacobsmeyer and CFO Crissy Carlisle will engage in a fireside chat at 9:00 a.m. ET. The event will be available for live streaming on the company's investor relations website. Enhabit operates 250 home health and 100 hospice locations across 34 states, focusing on enhancing patient care through technology and dedicated clinicians.
Enhabit, a national home health and hospice provider, has been recognized in Fortune’s “30 Best Large Workplaces in Health Care” and Modern Healthcare’s “Best Places to Work in Healthcare” awards. The company ranked #23 in Fortune's awards for the eighth consecutive year and #34 in Modern Healthcare's Provider/Insurer category. These accolades reflect Enhabit’s commitment to employee engagement and retention, crucial in the current healthcare labor shortage. Enhabit prioritizes work-life balance, professional development, and competitive benefits for its over 10,000 employees.
Enhabit, Inc. (NYSE: EHAB) announced its participation in the Credit Suisse 31st Annual Healthcare Conference in Palos Verdes, California, on November 8, 2022. President and CEO Barbara Jacobsmeyer, along with CFO Crissy Carlisle, will engage in a fireside chat at 5:00 p.m. ET. This session will be available via a live webcast on the company's investor relations website. Enhabit is a prominent home health and hospice provider, operating 250 home health and 100 hospice locations across 34 states, aiming to enhance patient care at home.
Enhabit, Inc. (NYSE: EHAB) reported its third quarter 2022 results, showing a 3.0% decline in net service revenue to $265.7 million compared to Q3 2021, and a significant 60.2% drop in net income to $8.6 million. Adjusted EBITDA fell 26.3% to $31.7 million. Home health services experienced growth, particularly in Medicare Advantage admissions, up 31.5% year-over-year. However, the company faces challenges from increased labor costs, a shift to non-episodic patients, and lower hospice volumes. Full-year guidance for net service revenue and adjusted EBITDA has been adjusted downward.
Enhabit, Inc. (NYSE: EHAB) will report its third-quarter results for the period ending September 30, 2022, after market close on November 1, 2022. A conference call will be held on November 2, 2022, at 10:00 a.m. Eastern to discuss the results. Interested participants can join by dialing 888-660-6150 (toll-free) or 929-203-0843 (international), with Conference ID: 5248158. The call can be accessed online via Enhabit's investor website.
Enhabit, Inc. (NYSE: EHAB) has acquired Caring Hearts Hospice, a local provider in Texas, effective October 1, 2022. This acquisition enhances Enhabit’s hospice service line by adding four new locations: Gun Barrel City, Mineola, Palestine, and Quinlan, Texas. The company, which ranks as the fourth largest Medicare-certified home health provider and the 12th largest hospice provider in the U.S., aims to expand its national footprint and improve patient care quality.
Enhabit Home Health & Hospice (NYSE: EHAB) announced its participation in key investor events, including the Jefferies Nashville Bus Tour on Aug. 31, 2022, and the Wells Fargo Healthcare Conference in Boston on Sept. 8, 2022. CEO Barbara Jacobsmeyer and CFO Crissy Carlisle will host a fireside chat on Sept. 8 at 4:20 p.m. ET, available via live webcast on their investor page. Enhabit operates 251 home health and 100 hospice locations across 34 states, focusing on innovative patient care solutions.
Enhabit Home Health & Hospice (NYSE: EHAB) reported a 6.3% decline in net service revenue to $268.0 million for Q2 2022, compared to Q2 2021. Net income fell 37.8% to $20.1 million. Adjusted EBITDA decreased 30.3% to $40.3 million, reflecting challenges in the healthcare sector, including labor costs and a shift to non-episodic payor mix. The company revised its full-year guidance, projecting net service revenue between $1,075 to $1,110 million and adjusted EBITDA between $155 to $170 million.